Document Page: First | Prev | Next | All | Image | This Release | Search

    ROUTINE                         U'N C L A S S I F I E D                TOO


        ZYTJW RHIPAAA4588   2882015--IJIJIJIJ--RHIHDAA RHx RMAA RHIPAAA RHIIJFAA
    ori s c r.
    ZNR UIJUUU
    R 15ISSSZ OCT 90
    FM LJSCINCCENT//rCJ3                                                         7-t;'
    TO RHIPAAA/COMUSARCENT MAIN//
    RHITMAA/CDMUSMARCENT//                                                      14it c
    RLJHGSCC/COMUSNAVCENT//
    RHIHDAA/COMSOCCENT//
    RHILJFAA/USCENTAF FWD HUS ELEMENT//
    BT
    UNCLAS
    OPER/UESERT SHIELD//
    MSOID/SYS. RRM/USCENTCOM
    AMPN/SUBJt USCENTCOM POLICY ON U.S.
    RMKS/I. DIAZEPAM, SOON TO BE       .FIELI]ED AS CANA (CONVULSANT ANTIDOTE
    FOR NERVE AGENT), IS CRITICAL IN PREVENTING OR REDUCING CONVULSIONS
    AND RESULTANT BRAIN DAMAGE IN NERVE AGENT CASLJAL.TXES. HOWEVER, THERE
    IS JUSTIFIABLE CONCERN THAT DIAZEPAM (ALSO KNOWN AS VALIUM) HAS THE
    POTENTIAL FOR ABUSE.
    2. 13IAZEPAM MUST BE ISSUED TO THE INDIVIDUAL, AND REA@TLY
    AVAILABLE WHEN NEE13EII, E)B' IT WILL- HE OF LITTLE USE IN PREVENTING
    PERMANENT BRAIN DAMAGE. THE BENEFITS OF INDIVIDUAL ISSUE FAR
    OUTWEIGH THE RISKS. THE SI13E EFFECTS FROM ADMIN15TERING CANA
    WITHGLJT BEING EXPOSED TO NERVE AGENT ARE MINIMAL (IMPAIRED VISI
           170C
    (&KING AND DECISION MAKING ABILITY FOR TWO TO FIVE HDLJRS).

    PAGE 02 RHIPAAA\\%% UNCLAS
    THERE 15 NO RISK OF PROLONGED INCAPACITATION OR ADDICTION WITH A
    SINGLE LJNALITHORIZED INJECTION.
    3. SINCE CANA CONTAINS A CONTROLLED SUBSTANCE, ALBEIT NOWHERE IN
    THE SAME CATEGORY AS A NARCOTIC, COMPONENT COMMANDERS WILL ENSURE
    ACCOUNTABILITY FOR IT W14EN ISSUED. THIS WILL BE ACCOMPLISHED
    THROUGH LOS BOOKS OR FORMS SIMILAR rO THOSE USED TO ISSUE WEAPONS
    OR ORGANIZATIONAL CLOTHING ANI) EQUIPMENT. FURTHERMORE,
    INDIVIDUALS MUST ATTEND A CLASS FOR ADMINISTERING FIRST AID TO A
    NERVE AGENT CASUALTY BEFORE BEING ISSUED THE CANA.
    4. THE INSTRUCTION WILL BE AN UPDATE OF THE BASIC FIRST-ATE) FOR
 AGENT CASUALTY THAT WILL INCORPORATE CANA INTO THE
    PROCEDURES FOR BUDDY--AID. WHEN AN IN13XVIDLJAL. HAS BEEN EXPOSED To
    SUFFICIENT NERVE AGENT SO THAT HE CAN NO LONGER HELP HIMSELF, HE
    REQUIRES BU13DY--AID. SEVERE NERVE AGENT CASLJAL.TIES WHO CANNOT
    INJECT THEMSELVES ARE GIVEN THEIR THREE ANTIDOTE SETS (ATROPINE
    ANr) 2 PAM CHLORIDE) IN RAPID SUCCESSION BY A BUDDY. WHEN A
    CASUALTY  ''S THIRD SET IS ADMINISTERED BY HIS BUDDY, THE BIJ013Y WILL
    -.THEN A13HINI@TER THE CANA.
    5. THE CLASS WFCL,,ALSO EMPHASIZE THE INDIVIDLJALS' RESPONSIBILITY
         AFESUARD THEIR CANA AUTOINJECTOR. THE INSTRUCTION WILL.


    ROL)TINE                 x       Lit4CL.ASSXFIEr)

                                                                                        57
Box ID = BX000000
Unit = G3 NBC SECTION  
Parent Organization = ARCENT          
Folder Title = CANA                                                                                            
Subject = USCENTCOM POLICY ON U.S. FORCES USE OF DIAZEPAM
Document Number =         45
Image file name = 00000048.tif

Document Page: First | Prev | Next | All | Image | This Release | Search